Top

BMC Oral Health

Published in:

Open Access 01-12-2023 | Periodontal Treatment | Research

Periodontitis is associated with the increased levels of visfatin: a meta-analysis

Authors: Junfei Zhu, Suhan Zhang, Jing Shi, Ning ning, Ying Wei, Ye Zhang

Published in: BMC Oral Health | Issue 1/2023

Abstract

Objective

Periodontitis is a common inflammatory disease associated with systemic factors. Visfatin is a pleiotropic adipokine that exerts metabolic and immune functions. Studies have shown visfatin played roles in the development of periodontitis. The present study aims to compare the levels of visfatin in body fluids including serum, saliva, and gingival crevicular fluid (GCF) between periodontitis patients and healthy individuals, and to elucidate the alteration of visfatin levels after periodontal treatments.

Materials and methods

The database searched included Pubmed, Embase, Web of Science, and Cochrane Library. According to the Eligibility criteria, the records were screened and the eligible studies were included. The methodological qualities of the included case-controlled studies were assessed according to the Newcastle–Ottawa scale (NOS). The Methodological Index for Nonrandomized Studies (MINORS) was applied for assessing the qualities of the included clinical trials. The statistical analyses were processed using STATA 15.0.

Results

Twenty-three studies were included in the statistical analyses. The meta-analysis showed significantly elevated visfatin levels of GCF, serum, and saliva in the periodontitis population compared with the controls (GCF: SMD = 5.201, 95% CI: 3.886–6.516, Z = 7.75, P < 0.05; Serum: SMD = 7.417, 95% CI: 3.068–11.767, Z = 3.34, P = P < 0.05; Saliva: SMD = 2.683, 95% CI: 1.202–4.163, Z = 3.34, P < 0.05). Visfatin levels of saliva serum and GCF were significantly decreased after periodontal treatment.

(Saliva: SMD = -1.338, 95% CI: -2.289—0.487, Z = 39.77, P < 0.05; Serum: SMD = -2.890, 95% CI: -5.300–0.480, Z = 2.35, P < 0.05; GCF: SMD = -6.075, 95% CI: -11.032—1.117, Z = 2.40, P = 0.016; I 2 = 95.9%, P < 0.05).

Conclusions

Periodontitis elevated the visfatin levels in GCF, serum, and saliva. Additionally, GCF, serum, and saliva visfatin levels could be reduced after periodontal treatment.

Slots J. Periodontitis: facts, fallacies and the future. Periodontol 2000. Periodontol. 2017;75(1):7–23.CrossRef

Wang Z, et al. The role of adiponectin in periodontitis: Current state and future prospects. Biomed Pharmacother. 2021;137:111358.CrossRefPubMed

Nwizu N, Wactawski-Wende J, Genco RJ. Periodontal disease and cancer: Epidemiologic studies and possible mechanisms. Periodontol 2000. 2020;83(1):213–33.CrossRefPubMedPubMedCentral

Sanz M, et al. Periodontitis and cardiovascular diseases: Consensus report. J Clin Periodontol. 2020;47(3):268–88.CrossRefPubMedPubMedCentral

Baeza M, et al. Effect of periodontal treatment in patients with periodontitis and diabetes: systematic review and meta-analysis. J Appl Oral Sci. 2020;28:e20190248.CrossRefPubMed

Giardullo L, et al. Adipokine role in physiopathology of inflammatory and degenerative musculoskeletal diseases. Int J Immunopathol Pharmacol. 2021;35:20587384211015030.CrossRefPubMedPubMedCentral

Unamuno X, et al. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest. 2018;48(9):e12997.CrossRefPubMed

Zhang Y, et al. Visfatin is regulated by interleukin-6 and affected by the PPAR-γ pathway in BeWo cells. Mol Med Rep. 2019;19(1):400–6.PubMed

Cheng Q, et al. Visfatin inhibits apoptosis of pancreatic β-cell line, MIN6, via the mitogen-activated protein kinase/phosphoinositide 3-kinase pathway. J Mol Endocrinol. 2011;47(1):13–21.CrossRefPubMed

10.

Bayani M, Pourali M, Keivan M. Possible interaction between visfatin, periodontal infection, and other systemic diseases: A brief review of literature. Eur J Dent. 2017;11(3):407–10.CrossRefPubMedPubMedCentral

11.

Kim SR, et al. Upregulation of thromboxane synthase mediates visfatin-induced interleukin-8 expression and angiogenic activity in endothelial cells. Biochem Biophys Res Commun. 2012;418(4):662–8.CrossRefPubMed

12.

Zhu J, et al. Association of circulating leptin and adiponectin with periodontitis: a systematic review and meta-analysis. BMC Oral Health. 2017;17(1):104.CrossRefPubMedPubMedCentral

13.

Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRefPubMedPubMedCentral

14.

Zhu J, et al. Interleukin-6-174G/C Polymorphism Contributes to Periodontitis Susceptibility: An Updated Meta-Analysis of 21 Case-Control Studies. Dis Markers. 2016;2016:9612421.CrossRefPubMedPubMedCentral

15.

Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.CrossRefPubMedPubMedCentral

16.

Abolfazli N, Jabali S, Saber FS, Babaloo Z, Shirmohammadi A. Effect of non-surgical periodontal therapy on serum and salivary concentrations of Visfatin in patients with chronic periodontitis. J Dent Res Dent Clin Dent Prospect. 2015;9(1):11–7. https://doi.org/10.15171/joddd.2015.003.

17.

Bahammam MA, Attia MS. Effects of systemic simvastatin on the concentrations of Visfatin, tumor necrosis factor-α, and interleukin-6 in gingival crevicular fluid in patients with type 2 diabetes and chronic periodontitis. J Immunol Res. 2018:8481735. https://doi.org/10.1155/2018/8481735.

18.

Çetiner D, Uraz A, Öztoprak S, Akça G. The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease. J Appl Oral Sci. 2019;27:e20180365. https://doi.org/10.1590/1678-7757-2018-0365.

19.

Chen F, et al. Detection of levels of serum visfatin and PGE2 in patients with periodontitis and their relationships with activity of periodontitis. J Jilin Univ Med Ed. 2018;44(3):563–7.

20.

Coutinho A, Reddy N, Chatterjee A, Khan MI. The Role of Visfatin (Adipocytokine) Biomarker in Oral Health and Diseases among Nonobese Indian Population: A Proteomic Assay. 2021;8(3):104–8. https://doi.org/10.1055/s-0041-1728690.

21.

Hamdi AQ, Sarhat ER, Ali NH, Sarhat TR. Evaluation of Lipocalin-2 and Visfatin, and Vitamin (D,C, and E) in Serum of Diabetic Patients with Chronic Periodontitis. Indian J Forensic Med Toxicol. 2021;15(2):1668–74. https://doi.org/10.37506/ijfmt.v15i2.14578.

22.

Mishra V, Shettar L, Bajaj M, Math AS, Thakur SL. Interlinking Periodontitis and Type 2 Diabetes Mellitus by Assessment of Crevicular Visfatin Levels in Health and in Disease Before and After Initial Periodontal Therapy. J Clin Diagn Res. 2016;10(8):ZC67–71. https://doi.org/10.7860/JCDR/2016/18656.8283.

23.

Mohamed HG, Idris SB, Mustafa M, Ahmed MF, Åstrøm AN, Mustafa K, et al. Impact of Chronic Periodontitis on Levels of Glucoregulatory Biomarkers in Gingival Crevicular Fluid of Adults with and without Type 2 Diabetes. PLoS One. 2015;10(5):e0127660. https://doi.org/10.1371/journal.pone.0127660.

24.

Mopidevi A, et al. Salivary visfatin concentrations in patients with chronic periodontitis: an analysis before and after periodontal therapy. Indian J Dent Res. 2019;30(6):864–9.CrossRefPubMed

25.

Özcan E, Saygun NI, Serdar MA, Bengi VU, Kantarcı A. Non-Surgical Periodontal Therapy Reduces Saliva Adipokine and Matrix Metalloproteinase Levels in Periodontitis. J Periodontol. 2016;87(8):934–43. https://doi.org/10.1902/jop.2016.160046.

26.

Özcan E, Saygun NI, Serdar MA, Kubar A, Bengi VU. Porphyromonas gingivalis and Epstein-Barr Virus Are Associated With Increased Levels of Visfatin in Gingival Crevicular Fluid. J Periodontol. 2016;87(4):443–51. https://doi.org/10.1902/jop.2015.150424.

27.

Özcan E, Saygun NI, Serdar MA, Kurt N. Evaluation of the salivary levels of visfatin, chemerin, and progranulin in periodontal inflammation. Clin Oral Investig. 2015;19(4):921–8. https://doi.org/10.1007/s00784-014-1308-0.

28.

Paul R, et al. Evaluation of association between Porphyromonas gingivalis and visfatin levels in chronic periodontitis patients. J Indian Soc Periodontol. 2020;24(6):530–4.CrossRefPubMedPubMedCentral

29.

Pradeep AR, Raghavendra NM, Ramchandra Prasad MV, Kathariya R, Patel SP, Sharma A. Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease. J Periodontol. 2011;82(9):1314–9. https://doi.org/10.1902/jop.2011.100690.

30.

Pradeep AR, Raghavendra NM, Sharma A, Patel SP, Raju A, Kathariya R, et al. Association of serum and crevicular visfatin levels in periodontal health and disease with type 2 diabetes mellitus. J Periodontol. 2012;83(5):629–34. https://doi.org/10.1902/jop.2011.110272.

31.

Raghavendra NM, Pradeep AR, Kathariya R, Sharma A, Rao A, Naik SB. Effect of non surgical periodontal therapy on gingival crevicular fluid and serum visfatin concentration in periodontal health and disease. Dis Markers. 2012;32(6):383–8. https://doi.org/10.3233/DMA-2012-0897.

32.

Rezaei M, Bayani M, Tasorian B, Mahdian S. The comparison of visfatin levels of gingival crevicular fluid in systemic lupus erythematosus and chronic periodontitis patients with healthy subjects. Clin Rheumatol. 2019;38(11):3139–43. https://doi.org/10.1007/s10067-019-04708-w.

33.

Saljoughi F, Nasri K, Bayani M. Gingival crevicular fluid levels of visfatin in patients with chronic periodontitis and polycystic ovary syndrome. Obstet Gynecol Sci. 2020;63(1): 87–93. https://doi.org/10.5468/ogs.2020.63.1.87.

34.

Saseendran G, et al. Comparative evaluation of salivary visfatin levels in healthy and periodontally diseased patients before and after scaling and root planing. J Pharm Bioallied Sci. 2021;13(5):S624–8.CrossRefPubMedPubMedCentral

35.

Tabari ZA, Azadmehr A, Nohekhan A, Naddafpour N, Ghaedi FB. Salivary visfatin concentrations in patients with chronic periodontitis. J Periodontol. 2014;85(8):1081–5. https://doi.org/10.1902/jop.2013.130388.

36.

Tabari ZA, Ghaedi FB, Azadmehr A, Nohekhan A, Tabrizi MAA, Ardakani MRT, et al. Salivary Visfatin Concentration in Response to Non-surgical Periodontal Therapy. J Clin Diagn Res. 2015;9(4):ZC05–ZC08. https://doi.org/10.7860/JCDR/2015/11537.5773.

37.

Wu Y, Chen L, Wei B, Luo K, Yan F. Effect of non-surgical periodontal treatment on visfatin concentrations in serum and gingival crevicular fluid of patients with chronic periodontitis and type 2 diabetes mellitus. J Periodontol . 2015;86(6):795–800. https://doi.org/10.1902/jop.2015.140476.

38.

Ziaei N, Golmohammadi S, Ataee M, Ardalani F, Abbasi MM. Effect of non-surgical periodontal treatment on three salivary adipokines in diabetic patients with periodontitis. J Dent Res Dent Clin Dent Prospects. 2020;14(3):199–205. https://doi.org/10.34172/joddd.2020.029.

39.

Akram Z, et al. Cytokine Profile in Chronic Periodontitis Patients with and without Obesity: A Systematic Review and Meta-Analysis. Dis Markers. 2016;2016:4801418.CrossRefPubMedPubMedCentral

40.

Akram Z, et al. Resistin as potential biomarker for chronic periodontitis: A systematic review and meta-analysis. Arch Oral Biol. 2017;73:311–20.CrossRefPubMed

41.

Samal B, et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol. 1994;14(2):1431–7.PubMedPubMedCentral

42.

Moschen AR, et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol. 2007;178(3):1748–58.CrossRefPubMed

43.

Luk T, Malam Z, Marshall JC. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol. 2008;83(4):804–16.CrossRefPubMed

44.

Karampela I, Christodoulatos GS, Dalamaga M. The Role of Adipose Tissue and Adipokines in Sepsis: Inflammatory and Metabolic Considerations, and the Obesity Paradox. Curr Obes Rep. 2019;8(4):434–57.CrossRefPubMed

45.

Saadoun MM, et al. Serum Visfatin as a Diagnostic Marker of Active Inflammatory Bowel Disease. J Gastrointestin Liver Dis. 2021;30(3):339–45.CrossRefPubMed

46.

Polyakova YV, et al. Visfatin and Rheumatoid Arthritis: Pathogenetic Implications and Clinical Utility. Curr Rheumatol Rev. 2020;16(3):224–39.CrossRefPubMed

47.

Radzicka S, et al. The role of visfatin in pathogenesis of gestational diabetes (GDM). Ginekol Pol. 2018;89(9):518–21.CrossRefPubMed

48.

Dakroub, A., et al., Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders. Cells, 2020. 9(11).

49.

Kocher T, et al. Periodontal complications of hyperglycemia/diabetes mellitus: Epidemiologic complexity and clinical challenge. Periodontol 2000. 2018;78(1):59–97.CrossRefPubMed

50.

Chen Z, et al. Research on the correlation of diabetes mellitus complicated with osteoporosis with lipid metabolism, adipokines and inflammatory factors and its regression analysis. Eur Rev Med Pharmacol Sci. 2017;21(17):3900–5.PubMed

51.

Barros SP, et al. Gingival crevicular fluid as a source of biomarkers for periodontitis. Periodontol 2000. 2016;70(1):53–64.CrossRefPubMedPubMedCentral

52.

Buduneli N, Kinane DF. Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J Clin Periodontol. 2011;38(Suppl 11):85–105.CrossRefPubMed

53.

Papagerakis P, et al. Saliva and Gingival Crevicular Fluid (GCF) Collection for Biomarker Screening. Methods Mol Biol. 2019;1922:549–62.CrossRefPubMed

54.

Cecoro, G., et al., Periodontitis, Low-Grade Inflammation and Systemic Health: A Scoping Review. Medicina (Kaunas), 2020. 56(6).

Title: Periodontitis is associated with the increased levels of visfatin: a meta-analysis
Authors: Junfei Zhu
Suhan Zhang
Jing Shi
Ning ning
Ying Wei
Ye Zhang
Publication date: 01-12-2023
Publisher: BioMed Central
Keyword: Periodontal Treatment
Published in: BMC Oral Health / Issue 1/2023
Electronic ISSN: 1472-6831
DOI: https://doi.org/10.1186/s12903-023-03384-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Periodontitis is associated with the increased levels of visfatin: a meta-analysis

Abstract

Objective

Materials and methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2023

Knowledge and attitudes toward evidence-based cariology and restorative dentistry among Egyptian dental practitioners: a cross-sectional survey

Effect of shelf-storage temperature on degree of conversion and microhardness of composite restorative materials

Changes in the Oral-Health-Related Quality of Life of Thai patients with oral lichen planus after topical corticosteroid treatment: a 1-month longitudinal study

Oral health-related quality of life, impaired physical health and orofacial pain in children and adolescents with juvenile idiopathic arthritis – a prospective multicenter cohort study

Investigating oral health among US adults with sleep disorder: a cross-sectional study

Heterogeneity of outcomes in randomized controlled trials on implant prosthodontic therapy is hindering comparative effectiveness research: meta-research study